We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

Share
  • Facebook
  • Twitter
  • Linked In
  • Google+
back top
FDA approves first autologous cellularized scaffold for the repair of cartilage defects of the knee

1300 members from 70 countries Join ICRS

FDA approves first autologous cellularized scaffold for the repair of cartilage defects of the knee

The US Food and Drug Administration (FDA) has approved autologous cultured chondrocytes on porcine collagen membrane (Maci, Vericel Corp) for the repair of symptomatic, full-thickness cartilage defects of the knee in adults.

Maci is the first FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient’s own knee, the FDA said.

Read More

The US Food and…
ICRShttps://cartilage.org/content/uploads/icrs.jpg
FDA approves first autologous cellularized scaffold for the repair of cartilage defects of the knee